Drug Device Combination Products Market, By Product (Infusion Pumps (Volumetric, Disposables, Syringes, Ambulatory, Implantable, and Insulin), Orthopedic Combination Products (Bone Graft Implants and Antibiotic Bone Cement), Photodynamic Therapy Devices, Transdermal Patches, Drug Eluting Stents (Coronary Stents and Peripheral Vascular Stents), Wound Care Products, Inhalers (Dry Powder, Nebulizers, and Metered Dose), Antimicrobial Catheters (Urological, Cardiovascular, and Others), and Others) By Wound Type (Cardiovascular Disease, Diabetes, Respiratory Problem, Cancer Treatment, Antimicrobial Application, and Other Applications (Neurological, Skin Treatments, Etc.)), By End-User (Hospital and Clinic, Ambulatory Surgery Center (ASC), and Home Care Setting), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) - Trends, Analysis and Forecast till 2030

Drug device combination product is a product composed of any combination of a drug and a device which is a biological product and a device. Drug device combination product is composed of two or more regulated components which are physically, chemically, or otherwise combined or mixed and produced as single entity. For instance, monoclonal antibody combined with a therapeutic drug and device coated or impregnated with a drug or biologic.Drug Device Combination Product Market accounted for US$ 130.4 billion in 2020 and is estimated to be US$ 277.9 billion by 2030 and is anticipated to register a CAGR of 7.8%.

Increasing preference for minimally invasive procedures

Increasing preference for minimally invasive procedures by patient and physician consistent-dosing treatment has been an alternative, which drives the drug device combination products market. In addition, increasing prevalence of chronic diseases such as hyper tension, obesity, cancer, diabetes, etc. propels the target market. Furthermore, rising adoption of drug device combination products due to its benefits such as reduced pain levels, better patient outcome, reduced hospitals stay, and overall healthcare cost efficiency fuels the drug device combination products market.

Increasing concerns of government

Moreover, increasing concerns of government along with health organizations to ensure high patient safety boosts the target market. For instance, in August 2018, FDA approves first generic version of EpiPen and EpiPen Jr (epinephrine) which is auto-injector products referred as “combination products”. They consist of a drug which is epinephrine and a device is the auto-injector.

Increasing demand for advanced medication delivery technologies across the globe augments the drug device combination products market. However, strict regulatory rule may hamper the target market.

The drug device combination products market on the basis of product, wound type, end-user, and region.

On the basis of product, the target market is segmented into infusion pumps, orthopedic combination products, photodynamic therapy devices, transdermal patches, drug eluting stents, wound care products, inhalers, antimicrobial catheters, and others. Infusion pumps sub-segment is categorized into volumetric, disposables, syringes, ambulatory, implantable, and insulin. Further, orthopedic combination products sub-segment is bifurcated into bone graft implants and antibiotic bone cement. Drug eluting stent sub-segment is divided into coronary stents and peripheral vascular stents. Inhalers product sub-segment is classified into dry powder, nebulizers, and metered dose. Antimicrobial catheters product sub-segment is categorized into urological, cardiovascular, and others. On the basis of wound type, the drug device combination products market is segmented into cardiovascular disease, diabetes, respiratory problem, cancer treatment, antimicrobial application, and other. Others sub-segment is divided into neurological, skin treatments, etc. On the basis of end-user, the target market is categorized into hospital and clinic, ambulatory surgery center (ASC), and home care setting.

Regional Insights:

For detailed understanding of market dynamics, the drug device combination products market is analyzed across key regions viz North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Each of these regions is analyzed on the basis of market findings across major countries in these regions for a macro-level understanding of the drug device combination products market. North America drug device combination products market is expected to account for major share in terms of revenue in the drug device combination products market over the forecast period. This can be attributed to increasing prevalence of chronic diseases, coupled with increased research and development by prominent players to launch new product in countries of the region. For instance, according to data published by National Center for Biotechnology Information, in 2018, in the U.S. approximately 45% or 113 million of American suffer from at least one chronic disease. Asia Pacific drug device combination products market is expected to account for significant share in terms of revenue in the target market in the near future. This is owing to rising awareness regarding drug device combination products along with growing R&D investments by drug device combination products market players in countries such as India and China of the region.

Detailed Segmentation:

Drug Device Combination Products Market, By Product:

• Infusion pumps
  • Volumetric
  • Disposables
  • Syringes
  • Ambulatory
  • Implantable
  • Insulin
• Orthopedic combination products
  • Bone Graft Implants
  • Antibiotic Bone Cement
• Photodynamic therapy devices
• Transdermal patches
• Drug eluting stents
  • Coronary stents
  • Peripheral vascular stents
• Wound care products
• Inhalers
  • Dry powder
  • Nebulizers
  • Metered dose
• Antimicrobial catheters
  • Urological
  • Cardiovascular
  • Others
• Others

Drug Device Combination Products Market, By Wound Type:

• Cardiovascular disease
• Diabetes
• Respiratory problem
• Cancer treatment
• Antimicrobial application
• Other applications (neurological, skin treatments, etc.)

Drug Device Combination Products Market, By End-User:

• Hospital and clinic
• Ambulatory surgery center (ASC)
• Home care setting

Drug Device Combination Products Market, By Region:

• North America
  • Middle East & Africa
    • Middle East & Africa Drug Device Combination Products Market, By Product
    • Middle East & Africa Drug Device Combination Products Market, By Wound Type
    • Middle East & Africa Drug Device Combination Products Market, By End-User
    • Middle East & Africa Drug Device Combination Products Market, By Country
      • GCC
      • Israel
      • South Africa
      • Rest of Middle East & Africa
  • Latin America
    • Latin America Drug Device Combination Products Market, By Product
    • Latin America Drug Device Combination Products Market, By Wound Type
    • Latin America Drug Device Combination Products Market, By End-User
    • Latin America Drug Device Combination Products Market, By Country
      • Brazil
      • Mexico
      • Rest of Latin America
  • Asia Pacific
    • Asia Pacific Drug Device Combination Products Market, By Product
    • Asia Pacific Drug Device Combination Products Market, By Wound Type
    • Asia Pacific Drug Device Combination Products Market, By End-User
    • Asia Pacific Drug Device Combination Products Market, By Country
      • China
      • India
      • Japan
      • South Korea
      • Rest of Asia Pacific
  • Europe
    • Europe Drug Device Combination Products Market, By Product
    • Europe Drug Device Combination Products Market, By Wound Type
    • Europe Drug Device Combination Products Market, By End-User
    • Europe Drug Device Combination Products Market, By Country
      • Germany
      • UK
      • France
      • Russia
      • Italy
      • Rest of Europe
  • North America Drug Device Combination Products Market, By Product
  • North America Drug Device Combination Products Market, By Wound Type
  • North America Drug Device Combination Products Market, By End-User
  • North America Drug Device Combination Products Market, By Country
    • U.S.
    • Canada

Some of the prominent players operating in the drug device combination products market include Abbott Laboratories, Terumo Corporation, Stryker Corporation, Mylan N.V., Medtronic plc, Allergan plc, Boston Scientific Corporation, Novartis AG, Becton Dickinson, and Cipla Limited. Key players are engaged new product development activities, and mergers and acquisitions which have significantly contributed to their growth. For instance, on 12 April 2019, Cipla Limited launched “Niveoli” inhaler, is a new product combination formulations and drug-device combinations in the respiratory therapy.

• Abbott Laboratories
  • Company Overview
    • Financial Performance
    • Key Highlights
    • Product Portfolio

• Terumo Corporation
  • • • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance

• Stryker Corporation
  • • • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance

• Mylan N.V.
  • • • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance

• Medtronic plc
  • • • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance

• Allergan plc
  • • • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance

• Boston Scientific Corporation
  • • • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance

• Novartis AG
  • • • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance

• Becton Dickinson
  • • • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance

• Cipla Limited
  • • • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance